A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.

by Hao Zhang, Dror Berel, Yanping Wang, Ping Li, Neil A Bhowmick, Robert A Figlin, Hyung L Kim
Published 2013-01-01

Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients

by Ali-Reza Sharif-Afshar, Christopher Nguyen, Tom S. Feng, Lucas Payor, Zhaoyang Fan, Rola Saouaf, Debiao Li, Hyung L. Kim
Published 2016-05-01

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)

by Hyung L. Kim, Susan Halabi, Ping Li, Greg Mayhew, Jeff Simko, Andrew B. Nixon, Eric J. Small, Brian Rini, Michael J. Morris, Mary-Ellen Taplin, Daniel George
Published 2015-11-01

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis

by Joseph M. Norris, Benjamin S. Simpson, Marina A. Parry, Clare Allen, Rhys Ball, Alex Freeman, Daniel Kelly, Hyung L. Kim, Alex Kirkham, Sungyong You, Veeru Kasivisvanathan, Hayley C. Whitaker, Mark Emberton
Published 2020-07-01

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

by Xiaona Wei, Yukti Choudhury, Weng Khong Lim, John Anema, Richard J. Kahnoski, Brian Lane, John Ludlow, Masayuki Takahashi, Hiro-omi Kanayama, Arie Belldegrun, Hyung L. Kim, Craig Rogers, David Nicol, Bin Tean Teh, Min-Han Tan
Published 2017-08-01

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.

by Chen Shao, Chun-Peng Liao, Peizhen Hu, Chia-Yi Chu, Lei Zhang, Matthew H T Bui, Christopher S Ng, David Y Josephson, Beatrice Knudsen, Mourad Tighiouart, Hyung L Kim, Haiyen E Zhau, Leland W K Chung, Ruoxiang Wang, Edwin M Posadas
Published 2014-01-01